wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37629874-28E7625F-E2C8-4E81-B458-22185A417B8A
Q37629874-28E7625F-E2C8-4E81-B458-22185A417B8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37629874-28E7625F-E2C8-4E81-B458-22185A417B8A
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
P2860
Q37629874-28E7625F-E2C8-4E81-B458-22185A417B8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37629874-28E7625F-E2C8-4E81-B458-22185A417B8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
031d607c08669d77a1c0efa5d33bf31cf8a4c78e
P2860
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.